Trademarkia Logo

Canada

C$
KROPSEN
REGISTERED

on 26 Jan 2024

Last Applicant/ Owned by

SUZHOU KINTOR PHARMACEUTICALS INC.

No.20, Songbei Road,Suzhou Industrial Park,Suzhou CityJiangsu Province

CN

Serial Number

2152705 filed on 15th Sept 2021

Registration Number

TMA1219779 registered on 26th Jan 2024

Registration expiry Date

15th Sept 2031

Correspondent Address

NEOMARK LTD.

7450 rue Saint-HubertMontréal

QUEBEC

CA

H2R2N3

KROPSEN

Trademark usage description

medicines for human purposes for the treatment of cancer, viral diseases, namely, herpes, hepatitis, acquired immune deficiency syndrome aids, dermati Read More

Vienna Information


24 . 15 . 21

Arrowheads -- Note: Not including arrowheads in the form of angles (26.3.23).Pointes de flèches -- Note: Non compris les pointes de flèches en forme d'angles (26.3.23).

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 6

Thick lines, bandsLignes épaisses, bandes

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

Classification Information


Class [005]
Medicines for human purposes for the treatment of cancer, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome AIDS, dermatitis and skin pigmentation diseases, infectious diseases, namely, respiratory infections, eye infections, topical infections, coronavirus diseases and COVID-19, acne, leukemia, hair loss; nutraceutical preparations for therapeutic and medical purposes, namely nutraceutical dietary supplement for maintaining general health and wellbeing; Pharmaceutical preparations for the treatment of cancer, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome AIDS, dermatitis and skin pigmentation diseases, infectious diseases, namely, respiratory infections, eye infections, topical infections, coronavirus diseases and COVID-19, acne, leukemia, hair loss; Chemico-pharmaceutical preparations for the treatment of cancer, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome AIDS, dermatitis and skin pigmentation diseases, infectious diseases, namely, respiratory infections, eye infections, topical infections, coronavirus diseases and COVID-19, acne, leukemia, hair loss; Drugs for medical purposes for the treatment of cancer, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome AIDS, dermatitis and skin pigmentation diseases, infectious diseases, namely, respiratory infections, eye infections, topical infections, coronavirus diseases and COVID-19, acne, leukemia, hair loss; Biological preparations for medical purposes for the treatment of cancer, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome AIDS, dermatitis and skin pigmentation diseases, infectious diseases, namely, respiratory infections, eye infections, topical infections, coronavirus diseases and COVID-19, acne, leukemia, hair loss; Chemical preparations for pharmaceutical purposes for the treatment of cancer, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome AIDS, dermatitis and skin pigmentation diseases, infectious diseases, namely, respiratory infections, eye infections, topical infections, coronavirus diseases and COVID-19, acne, leukemia, hair loss; Chemical preparations for medical purposes for the treatment of cancer, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome AIDS, dermatitis and skin pigmentation diseases, infectious diseases, namely, respiratory infections, eye infections, topical infections, coronavirus diseases and COVID-19, acne, leukemia, hair loss; nutraceutical preparations for therapeutic and medical purposes for the treatment of cancer, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome AIDS, dermatitis and skin pigmentation diseases, infectious diseases, namely, respiratory infections, eye infections, topical infections, coronavirus diseases and COVID-19, acne, leukemia, hair loss


Classification kind code

11

Mark Details


Serial Number

2152705

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 13th Mar 2023
Search Recorded
Submitted for opposition 20
on 13th Mar 2023
Examiner's First Report
Submitted for opposition 223
on 13th Mar 2023
Total Provisional Refusal
Submitted for opposition 256
on 10th Oct 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 9th Dec 2021
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 8th Dec 2021
Created
Submitted for opposition 31
on 8th Dec 2021
Formalized
Submitted for opposition 30
on 15th Sept 2021
Filed
Submitted for opposition 210
on 15th Sept 2021
IR Correction
Submitted for opposition 228
on 15th Sept 2021
International Registration